(+/-)-N-(-2-methylpiperidin-3-yl)benzo[d]oxazol-2-amine

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并恶唑类
• 英文名称: (+/-)-N-(-2-methylpiperidin-3-yl)benzo[d]oxazol-2-amine
• 英文别名: N-(2-methylpiperidin-3-yl)-1,3-benzoxazol-2-amine
• 化学式: C₁₃H₁₇N₃O
• 分子量: 231.29
• InChiKey: RHLNWGPHBXSJBR-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.6
• 重原子数：
  17
• 可旋转键数：
  2
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.461
• 拓扑面积：
  50.1
• 氢给体数：
  2
• 氢受体数：
  4

反应信息

• 作为产物：
  描述：

  (+/-)-Tert-butyl-3-((4,6-dimethylpyrimidin-2-yl)amino)-2-methylpiperidine-1-carboxylate 、 (+/-)-Tert-butyl 3-(benzo[d]oxazol-2-ylamino)-2-methylpiperidine-1-carboxylate 生成 (+/-)-N-(-2-methylpiperidin-3-yl)benzo[d]oxazol-2-amine
  参考文献：
  名称：

  Substituted piperidine compounds and their use as orexin receptor modulators

  摘要：

  本发明涉及公式I的化合物：其中X为CR1或N; Y为CR2或N; Z为NH或O; R1为烷氧基、三唑基、噁唑基、异噁唑基、噁二唑基或嘧啶基; R2为氢、烷基或卤素; R3为氢、烷基、烷氧基、卤素、三唑基、噁唑基或嘧啶基; R4为烷基; R5为吡啶基、苯并噁唑基、嘧啶基、吡啶嗪基、喹喔啉基、吡嗪基或喹唑啉基; 其中吡啶基、苯并噁唑基、嘧啶基、吡啶嗪基、喹喔啉基、吡嗪基或喹唑啉基可以选择地用一个或两个取代基独立地选自烷基、卤素或苯基; R6为氢或烷基。还描述了制备公式I化合物的方法。本发明还涉及包括公式I化合物的制药组合物。使用本发明化合物的方法也属于本发明的范围。

  公开号：

  US09115117B2

文献信息

• SUBSTITUTED PIPERIDINE COMPOUNDS AND THEIR USE AS OREXIN RECEPTOR MODULATORS
  申请人：COATE Heather R.

  公开号：US20160046599A1

  公开（公告）日：2016-02-18

  The present invention is directed to compounds of Formula I: wherein X is CR 1 or N; Y is CR 2 or N; Z is NH or O; R 1 is alkoxy, triazolyl, oxazolyl, isoxazolyl, oxadiazolyl, or pyrimidinyl; R 2 is H, alkyl, or halo; R 3 is H, alkyl, alkoxy, halo, triazolyl, oxazolyl, or pyrimidinyl; R 4 is alkyl; R 5 is pyridyl; benzoxazolyl; pyrimidinyl; pyridazinyl; quinoxalinyl; pyrazinyl; or quinazolinyl; wherein the pyridyl; benzoxazolyl; pyrimidinyl; pyridazinyl; quinoxalinyl; pyrazinyl; or quinazolinyl is optionally substituted with one or two substituents independently selected from the group consisting of alkyl, halo, or phenyl; and R 6 is H or alkyl. Methods of making the compounds of Formula I are also described. The invention also relates to pharmaceutical compositions comprising compounds of Formula I. Methods using the compounds of the invention are also within the scope of the invention.

  本发明涉及式I的化合物：其中X为CR1或N; Y为CR2或N; Z为NH或O; R1为烷氧基，三唑基，噁唑基，异噁唑基，噁二唑基或嘧啶基; R2为氢，烷基或卤素; R3为氢，烷基，烷氧基，卤素，三唑基，噁唑基或嘧啶基; R4为烷基; R5为吡啶基; 苯并噁唑基; 嘧啶基; 吡啶二氮杂苯基; 喹喔啉基; 吡嗪基; 或喹唑啉基; 其中吡啶基; 苯并噁唑基; 嘧啶基; 吡啶二氮杂苯基; 喹喔啉基; 吡嗪基; 或喹唑啉基可选地被一个或两个独立选择的取代基取代，所述取代基选自烷基，卤素或苯基; R6为氢或烷基。还描述了制备式I化合物的方法。本发明还涉及包含式I化合物的制药组合物。使用本发明中的化合物的方法也属于本发明的范围。
• US20140275095A1
  申请人：——

  公开号：——

  公开（公告）日：——
• US9115117B2
  申请人：——

  公开号：US9115117B2

  公开（公告）日：2015-08-25
• US9611251B2
  申请人：——

  公开号：US9611251B2

  公开（公告）日：2017-04-04
• [EN] SUBSTITUTED PIPERIDINE COMPOUNDS AND THEIR USE AS OREXIN RECEPTOR MODULATORS<br/>[FR] COMPOSÉS DE PIPÉRIDINE SUBSTITUÉE ET LEUR UTILISATION EN TANT QUE MODULATEURS DES RÉCEPTEURS D'OREXINE
  申请人：JANSSEN PHARMACEUTICA NV

  公开号：WO2014165065A1

  公开（公告）日：2014-10-09

  The present invention is directed to compounds of Formula I: wherein X is CR1 or N; Y is CR2 or N; Z is NH or O; R1 is alkoxy, triazolyl, oxazolyl, isoxazolyl, oxadiazolyl, or pyrimidinyl; R2 is H, alkyl, or halo; R3 is H, alkyl, alkoxy, halo, triazolyl, oxazolyl, or pyrimidinyl; R4 is alkyl; R5 is pyridyl; benzoxazolyl; pyrimidinyl; pyridazinyl; quinoxalinyl; pyrazinyl; or quinazolinyl; wherein the pyridyl; benzoxazolyl; pyrimidinyl; pyridazinyl; quinoxalinyl; pyrazinyl; or quinazolinyl is optionally substituted with one or two substituents independently selected from the group consisting of alkyl, halo, or phenyl; and R6 is H or alkyl. Methods of making the compounds of Formula I are also described. The invention also relates to pharmaceutical compositions comprising compounds of Formula I. Methods of using the compounds of the invention are also within the scope of the invention.